Diabetes Clinical Trials

Diabetes Australia – Vic provides this information as a service to the community and it is the responsibility of the individual to determine the appropriateness of participating in a study.

Diabetes Australia – Vic does not take any responsibility whatsoever arising out of individuals participating in a study and recommend them to seek their own advice from their ususal medical practitioner or any other appropriate source deemed necessary before consenting to participate.

Information about clinical trials

Diabetes clinical trials are an essential part of the development of new interventions and tests that may help to improve your diabetes or improve the health care of others.

As a consumer you might be interested to know information about

  • What is a clinical trial?
  • Why be part of a clinical trial?
  • How to be part of a clinical trial?
  • How to find a clinical trial?


The Australian Clinical Trials website contains general information that addresses all of these questions about clinical trials in Australia.

Diabetes trials


Useful links

Clinical Trials Connect : Clinical Trials Connect Pty Ltd (CTC) is an online patient recruitment service designed to help people interested in volunteering for medical research find clinical trials that are relevant to them.

Australian Clinical Trials: This website aims to provide reliable and up-to-date information and advice about clinical trials in Australia. It provides easy to understand information about clinical trials in Australia and how to become involved in a clinical trial.

Australian New Zealand Clinical Trials Registry: The Australian New Zealand Clinical Trials Registry (ANZCTR) is an online register of clinical trials being undertaken in Australia, New Zealand and elsewhere.

 


 

Attitudes toward depression and treatment options among Australians with a chronic illness

Do you have type 2 diabetes?

RMIT University is currently recruiting participants for research investigating attitudes towards depression in Australians who have a chronic illness.

This study will be looking at the relationship between beliefs about the cause of depression, attitudes toward depression, and the influence this has on seeking and adhering to treatment for depression.

If you wish to participate, it will take around 15 minutes of your time to complete a short survey!

Take the online survey

This research survey has been given ethics approval by RMIT Human Research Ethics Committee.

 


 

Type 2 Diabetes Motivation Questionnaire

  • Do you have type 2 diabetes?
  • Are you over 18 years of age?


The Queensland University of Technology invites you to participate in an online survey. The purpose of the survey is to develop a new measure of motivation that is applicable to individuals with type 2 diabetes.
The project team is interested in finding out if there are common barriers to type 2 diabetes self-management due to motivation.

For more information or to complete the survey visit the website. For further information about the survey please contact Sophie Parham on 07 3138 6143 or via email.
QUT Ethics Approval No: 1400000268


 Do you have type 2 diabetes?

The Department of Medicine at The Heidelberg Repatriation Hospital is currently recruiting patients for a clinical trial for type 2 diabetes.  You may be eligible to take part if you have type 2 diabetes and you are 18 years of age or older and you are taking no more than three different types of diabetes tablets or, on insulin therapy (either alone or with diabetes tablets).  The study will last for 4-7 years and is being performed at clinics throughout the world, including Australia. If eligible to participate, you will receive study-related tests and study drug at no cost.  You will be reimbursed for parking and study-related travel expenses.

This study has been approved by the Austin Health Human Research Ethics Committee: HREC 11/SVHM/4.

If interested, please contact Nicky Robinson from the Metabolic Disorders Centre, Heidelberg Repatriation Hospital on 03 9496 2645 or nbric@unimelb.edu.au



Heart attack…stroke…. are you at risk?


Heart attacks can happen at any time to anyone.  It is important to know if you are at risk.  There are many factors that increase your chances of having a heart attack including:

  • Previous Heart Attack
  • Heart Related Disease
  • High Cholesterol
  • High Blood Pressure
  • Diabetes


Local physicians are conducting a research study of an investigational medication and its ability to reduce your risk of having a heart attack and other cardiovascular events such as a stroke.  If you are currently taking a medication to lower your cholesterol and have one or more of the conditions listed above, you may qualify for participation in this study.  All testing, treatment and parking will be provided free of charge.

If interested, please contact Nicky Robinson from the Metabolic Disorders Centre, Heidelberg Repatriation Hospital on 03 9496 2645 or nbric@unimelb.edu.au

This project has been approved by the Austin Health and St Vincent’s Hospital (Melbourne) Human Research Ethics Committee: HREC 12/SVHM/2.


 

Do you have type 2 diabetes? Adult volunteers required now for investigational oral diabetes medication


If you have type 2 diabetes, and are between 18 and 75 years of age, find out if you qualify for a clinical research study of an investigational oral diabetes medication.  

You may eligible if your blood sugar is not well-controlled and you are being treated with Janumet or Metformin and Januvia.  If eligible to participate, you will be seen by a study doctor and receive study-related testing and medication at no costs.  

Trial visits are held at the Metabolic Disorders Centre, Austin Health, Heidelberg Repatriation Hospital.  All testing, treatment and parking will be provided free of charge.

If interested, please contact Nicky Robinson from the Metabolic Disorders Centre, Heidelberg Repatriation Hospital on 03 9496 2645 or nbric@unimelb.edu.au

This study has been approved by the Austin Health Human Research Ethics Committee: HREC 28431754DIA4004.


 

Do you have type 2 diabetes?

The research team at the Metabolic Disorders Centre, Heidelberg Repatriation Hospital are testing the effect of an investigational drug on cardiovascular events (heart attack and stroke) in patients with type 2 diabetes who may be at risk of these events.

If you are male or female aged 50 years or older have type 2 diabetes and have never had a heart attack or stroke, you may qualify for a clinical trial.

You will be medically supervised. There will be no costs involved. Visits are at the Metabolic Disorders Centre, Austin Health, Heidelberg Repatriation Hospital.

If interested, please contact Nicky Robinson from the Metabolic Disorders Centre, Heidelberg Repatriation Hospital on 03 9496 2645 or nbric@unimelb.edu.au


This project has been approved by the Austin Health and St Vincent’s Hospital (Melbourne) Human Research Ethics Committee D: HREC D513BC00001.


 

Obesity Study


The Metabolic Disorders Centre, Heidelberg Repatriation Hospital are currently studying the effects of a clinical trial medication in overweight patients with a history of heart disease, type 2 diabetes and multiple cardiac risk factors.

They are currently looking for volunteers with one or more of the conditions listed below:

  • Previous heart attack
  • Angioplasty or heart bypass surgery
  • Previous stroke or carotid surgery
  • A blocked artery in the leg which causes symptoms (pain, reduced walking)
  • Previous vascular surgery or amputation of lower limbs
  • Diabetes with high cholesterol and /or high blood and/or reduced kidney function


This is a large investigational study involving approximately 12,000 patients worldwide. Trial visits are held at the Metabolic Disorders Centre, Austin Health, Heidelberg Repatriation Hospital.  All testing, treatment and parking will be provided free of charge.  

If interested, please contact Nicky Robinson from the Metabolic Disorders Centre, Heidelberg Repatriation Hospital on 03 9496 2645 or nbric@unimelb.edu.au

This project has been approved by the Austin Health and St Vincent’s Hospital (Melbourne) Human Research Ethics Committee D: HREC APD356-G000401.



Do you have type 2 diabetes and vascular disease?


The Metabolic Disorders Centre at Austin Health are testing a new treatment for type 2 diabetes and vascular disease (which is a disease of the blood vessels that causes reduced blood flow to some parts of the body such as the heart, the brain or the limbs).

If you are over 40 and have type 2 diabetes and vascular disease you may qualify to take part in this study. Trial visits are held at the Metabolic Disorders Centre, Austin Health, Heidelberg Repatriation Hospital.  All testing, treatment and parking will be provided free of charge.

If interested, please contact Nicky Robinson from the Metabolic Disorders Centre, Heidelberg Repatriation Hospital on 03 9496 2645 or nbric@unimelb.edu.au

This study has been approved by the Austin Health Human Research Ethics Committee: HREC MK8835-004/B1521021

 


 

Personality and chronic illness

Do you have type 2 diabetes?

Researchers from Deakin University invite you to complete a short online questionnaire related to symptoms, social support, health behaviour and personality.

Take the questionnaire.

For further information about this research please contact Daniel Chamravi via email.

This study has received ethics approval from the Deakin University Human Ethics Advisory Group



 

Weight Loss Maintenance Study

People aged 18-65 years are invited to participate in an online study investigating why weight loss maintenance is so difficult & what can be done to improve successful weight loss. Participants will go into the draw to win one of two $100 gift vouchers. The study is being conducted by Ms. Jessica Newhouse, Candidate, Doctor of Psychology (Health). For further information please visit the Facebook page, or contact Jessica; jessica.newhouse@deakin.edu.au. To participate in the study please click here.

Ethics approval for this study has been granted by the Human Research Ethics Unit of Deakin University.

 


 

Type 1 diabetes TrialNet


Type 1 Diabetes TrialNet is a network of 18 clinical centres dedicated to conducting diabetes prevention research and studying intervention therapies for children and adults with newly diagnosed diabetes.

TrialNet in Australia is screening relatives of people with type 1 diabetes to find out if these family members are at risk for developing diabetes. Screening involves a simple blood test for the presence of diabetes-related autoantibodies that may appear years before type 1 diabetes develops.

You may be screened to determine your risk of diabetes if;

  • are between 1 and 45 years of age and have a first degree blood relative (brother, sister, child, parent) with type 1 diabetes, OR
  • you are between 1 and 20 years of age and have a second degree blood relative (grandparent, half-brother, or half-sister with type 1 diabetes) with type 1 diabetes.


Relatives of people with type 1 diabetes have about a 5 percent chance of testing positive for autoantibodies associated with diabetes.

There is no cost for the test.

How Will You Benefit From Screening and Further Risk Assessment?

If you learn you are at risk for developing type 1 diabetes, additional tests will be offered to estimate your chances of developing type 1 diabetes. If you qualify, you may have an opportunity to be enrolled in either the Natural History or a prevention study. All research volunteers will be closely monitored for early detection of type 1 diabetes.

You will be part of a research program that may help other people at risk for type 1 diabetes.

For further information about this research visit the TrialNet website or contact Felicity Healy via email or phone 03 9342 7063


 

 Recently diagnosed with type 2 diabetes?

Researchers from Griffith University want to learn more about how people with type 2 diabetes feel about the food that they eat, and their experiences with receiving advice about it.

Researchers want to improve the care and information that health professionals can offer to support those living with type 2 diabetes.

If you have been diagnosed with type 2 diabetes in the past 3 months or so, you are invited to take part in a series of three telephone interviews that will last about 30 minutes each and will follow your experience over six months. Your participation will remain anonymous.

For more information, or to take part, please contact Lauren Ball on 07 5678 7342 or via email L.Ball@griffith.edu.au or Ruth Davmor via email K.Davmor@griffith.edu.au

 


 

The Sadness Program: Depression and diabetes

  •  Do you have diabetes – either type 1 or 2?
  • Do you have depression?
  • Are you aged over 18 years?
  • Do you have access to a computer with internet access and printer?

 
If  you  meet  these  criteria  then you might be interested in participating in research that is being conducted by St Vincent’s Hospital – Sydney. They are conducting a Randomised Controlled Trial of an online treatment for depression.

The study involves completing 6 lessons over 10 weeks, at no charge.

Eligible applicants will be randomly allocated to either:

A group commencing the program shortly after enrolment or

A group who will be offered the online treatment after a 10 week waiting period.

For more information about this program please call 02 8382 1400 or visit the website.

 



Kidney health during pregnancy

  • Do you have diabetes – either type 1 or 2?
  • Are you female < 40 years old?
  • Are you planning a pregnancy or within the first 12 weeks of pregnancy?


If you meet the above criteria then you might be interested in this study.

During pregnancy, the woman’s body undergoes remarkable changes, including the kidneys.

This study involves blood tests and ultrasounds of the kidneys (NO radiation), before (if possible), during and after your pregnancy.

To find out more about the study, please download the information flyer and letter of invitation to participate in research.

Please contact Jas-mine Seah on 03 9496 2288, 0412 931 059 or email for further information.

 


 


Health Benefits of Exercise, Protein and Vitamin D for Type 2 Diabetes

Come and join a new study conducted by Deakin University in Burwood to investigate the health benefits of vitamin D and protein combined with resistance training versus resistance exercise alone, in the management of type 2 diabetes.

You can take part in this trial if you;

  • Have type 2 diabetes
  • Are aged 50 years or over


From your involvement in this study you will receive;

  • free assessment of your muscle strength and function
  • free bone density and body composition assessments
  • free blood lipid and cholesterol measures
  • free assessment of your vitamin D levels


For further information, please contact Eliza Miller on 03 9244 6739 or email e.miller@deakin.edu.au  or Belinda DeRoss on 03 9246 8286 or email b.deross@deakin.edu.au
 

 


 

Seeking overweight or obese individuals with type 2 diabetes

Baker IDI Heart & Diabetes Institute is conducting a study to examine how weight loss influences stress hormones and the nervous system.

To be eligible you need to be:

  • Male or female with type 2 diabetes
  • Not on drug treatments (diet managed)
  • Aged 45 to 65 years
  • A non-smoker
  • Body mass index (BMI) > 27 kg/m2
  • Post-menopausal (women)


The study has been approved by the Alfred Hospital Ethics Committee

For further information about the study download the information flyer, or contact Dr Nora Straznicky on 03 8532 1371 or email nora.straznicky@bakeridi.edu.au

 


 

 

 Do you look after someone at home? Call for volunteers aged 55+ to participate in research at home

 The National Ageing Research Institute (NARI), together with Carers Victoria and the University of Melbourne are undertaking a project to investigate the effectiveness of a physical activity program on depression among people who are carers (that is, people who care for someone at home).

You can help us with the IMPACCT study if you:

  • are 55 years of age or over
  • are caring for & living with someone who is aged 60 years or over,
  • have recently experienced a lower mood than usual or symptoms of depression
  • live within Metropolitan Melbourne, Ballarat or Geelong Regions

 

To find out more information about this project, please download the information flyer and contact Edwina McCarthy on 03 8387 2315 or email e.mccarthy@nari.unimelb.edu.au

 


 


OnTrack Diabetes

Do you want more support in better managing Type 2 Diabetes? Do you want to help evaluate a new online learning program.

The OnTrack Diabetes Program is a free online program that supports people with Type 2 diabetes to set and maintain their own goals to improve and maintain diabetes self-care, glycaemic control and emotional wellbeing.

You may match the criteria for entry into this study if:

  • You have type 2 diabetes
  • Live in Australia
  • Are aged 18 – 75 years
  • Have regular internet access


For further information about the trial please vist the OnTrack Diabetes website or email Sophie Parham SParham@wesleyresearch.com.au

 


 

 

Do you have type 2 diabetes and elevated urinary protein?

Baker IDI Heart and Diabetes Institute is currently examining whether a new treatment, called moxonidine, helps to lower urinary protein excretion, a major risk factor for kidney and cardiovascular complications.

To be eligible to participate you must be aged between 18 and 75 years, have type 2 diabetes and have elevated levels of protein in your urine.

For further information about the trial contact Tye Dawood on 03 8532 1228 or tye.dawood@bakeridi.edu.au

 


 

ENDIA Study – Finding the causes of Type 1 Diabetes in Early Childhood


If you are planning or expecting a baby, or have a baby less than 6 months old, and

  • The baby’s mother or father has Type 1 Diabetes, or
  • You have another child with Type 1 Diabetes


Then your family may be eligible to participate in the ENDIA Study

The ENDIA (Environmental Determinants of Islet Autoimmunity) study is finding out what causes Type 1 Diabetes so we can find ways to prevent it. We already know that a child’s genes can increase their risk of developing Type 1 Diabetes. However, Type 1 Diabetes in children is twice as common in Australia as it was 20 years ago. This is because our environment has changed. If we can understand exactly what in the environment is harmful or protective, we can modify the environment to try and prevent Type 1 Diabetes.

This research trial has been reviewed and approved by the Human Research Ethics Committees (HRECs) representing the various sites that are participating in ENDIA.

For more information vist the ENDIA website, download the flyer or email endia@adelaide.edu.au

 

TOP